CLCMF(CLCMF)
CLCMF
Q4 2026 EPS Estimate
$0.09
Nov 5, 2026
Revenue Estimate
$719M
FY2026E EPS$3.19
FY2027E EPS$3.71
No analyst ratings available
No analyst price targets available for CLCMF
Analyst coverage may not be available for this symbol
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+5.40%
EPS+16.32%
FY2028
Rev+5.05%
EPS+8.83%
FY2029
Rev+1.51%
EPS+24.97%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $27.64B | $29.14B | $30.61B | $31.07B |
| Low | $27.10B | $28.59B | $30.02B | $30.47B |
| High | $28.18B | $30.01B | $31.37B | $31.84B |
| EBITDA Avg | $7.29B | $7.69B | $7.90B | $9.03B |
| Low | $7.19B | $7.57B | $7.77B | $8.87B |
| High | $7.43B | $7.85B | $8.07B | $9.24B |
| EBIT Avg | $5.32B | $5.99B | $6.42B | $7.72B |
| Low | $5.21B | $5.87B | $6.29B | $7.56B |
| High | $5.45B | $6.15B | $6.58B | $7.93B |
| Net Income Avg | $2.66B | $3.09B | $3.37B | $4.21B |
| Low | $2.59B | $3.02B | $3.28B | $4.10B |
| High | $2.74B | $3.19B | $3.47B | $4.34B |
| EPS Avg | $3.19 | $3.71 | $4.03 | $5.04 |
| Low | $3.11 | $3.61 | $3.93 | $4.91 |
| High | $3.29 | $3.82 | $4.16 | $5.20 |
| Analysts (Rev / EPS) | 7 / 1 | 8 / 1 | 5 / 1 | 6 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $6.96B | $7.25B | $6.98B |
| Low | $6.63B | $7.04B | $6.72B |
| High | $7.18B | $7.60B | $7.26B |
| EBITDA Avg | $1.92B | $1.93B | — |
| Low | $1.87B | $1.88B | — |
| High | $1.97B | $1.98B | — |
| EBIT Avg | $1.38B | $1.41B | — |
| Low | $1.33B | $1.36B | — |
| High | $1.43B | $1.46B | — |
| Net Income Avg | $610M | $626M | — |
| Low | $580M | $595M | — |
| High | $642M | $659M | — |
| EPS Avg | $0.86 | $0.88 | — |
| Low | $0.81 | $0.84 | — |
| High | $0.90 | $0.93 | — |
| Analysts (Rev / EPS) | 6 / 1 | 6 / 1 | 3 / — |
Earnings Surprises
Recent Analyst Actions
No recent analyst actions
